Dr. Reddy's Laboratories Limited

Equities

DRREDDY

INE089A01023

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:52 2024-03-28 am EDT 5-day change 1st Jan Change
6,155 INR +1.78% Intraday chart for Dr. Reddy's Laboratories Limited +0.88% +6.16%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Asian Equities Traded in the US as American Depositary Receipts Nudge Lower in Thursday Trading MT
Dr. Reddy's Laboratories Signs Deal to Distribute Sanofi's Vaccine Brands MT
Asian Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading MT
Dr. Reddy's Labs Secures Marketing Rights to Treatment for Hypovolemic Shock in India, Nepal MT
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Slightly Lower in Friday Trading MT
Dr. Reddy's Board to Consider Dividend for Fiscal 2024 MT
Pharmazz Inc. and Dr. Reddy's Laboratories Limited Enter into A Licensing Agreement to Market Centhaquine as A Resuscitative Agent for Hypovolemic Shock in India CI
Asian Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading MT
Asian Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading MT
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading MT
Dr. Reddy?s Laboratories Ltd. Launches Versavo® (Bevacizumab) in United Kingdom CI
Losses Led by IT Drag Indian Equities on Tuesday MT
Dr. Reddy's Laboratories Launches Versavo Drug in UK MT
Asian Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher in Monday Trading MT
Asian Equities Traded in the US as American Depositary Receipts End Week Lower in Friday Trading MT
Dr. Reddy's Laboratories Limited Approves Incorporation of A Wholly-Owned Subsidiary of the Company CI
Asian Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading MT
Dr. Reddy's Laboratories Limited Receives an Order from GST Authority Towards Tax Demand Including Interest and Carbon CI
Asian Equities Traded in the US as American Depositary Receipts Rally in Tuesday Trading MT
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading MT
Asian Equities Traded in the US as American Depositary Receipts Surge Higher in Friday Trading, Led by Tech, Bank Stocks MT
Upbeat Global Markets, Strong GDP Send Indian Equities to Record Closing High on Friday MT
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading MT
Bank, Auto Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Sharply Lower Wednesday MT
Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading MT
Chart Dr. Reddy's Laboratories Limited
More charts
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows: - sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines; - sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services; - other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc. Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
36
Last Close Price
6,155 INR
Average target price
5,978 INR
Spread / Average Target
-2.88%
Consensus